Skip to main content
. 2024 Feb 19;27(4):161. doi: 10.3892/ol.2024.14293

Figure 2.

Figure 2.

Analyses of progression-free survival. (A) Kaplan-Meier estimates of progression-free survival and (B) Forest plot of progression-free survival according to various patient subgroups. HR, hazard ratio; CI, confidence interval; AS, nab-paclitaxel plus S-1; GS, gemcitabine plus S-1.